David Wallach
About David Wallach
David Wallach is the Director of Research Regulatory Services at NYU Langone Health and a member of the Working Group on Compassionate Use and Pre-Approval Access (CUPA). He has extensive experience in research regulatory services and has held various roles at Albert Einstein College of Medicine.
Company: NYU Langone Health
David Wallach currently serves as the Director of Research Regulatory Services at NYU Langone Health, a position he has held since 2016. In this role, Wallach oversees the regulatory compliance and ethical standards for research activities within the institution. His responsibilities include ensuring that research protocols adhere to federal regulations, institutional policies, and ethical guidelines.
Title: Director, Research Regulatory Services
David Wallach is the Director of Research Regulatory Services at NYU Langone Health. His role includes overseeing the regulatory aspect of research projects, ensuring all studies comply with ethical standards and federal regulations. He works closely with research teams to facilitate compliance and support organizational research objectives.
Education and Expertise
David Wallach holds a Master of Public Health (MPH) from Albert Einstein College of Medicine of Yeshiva University, earned between 2010 and 2014. He also holds a Bachelor of Arts (BA) in Computer Science from Yeshiva University, completed from 1997 to 2001. Additionally, he earned a Certificate in Public Health (CPH) from Yeshiva University between 2009 and 2010. His expertise spans diverse areas including public health, computer science, and the ethical regulation of investigational products.
Background in Health and Research
David Wallach has an extensive background in health and research-related fields. His previous roles at Albert Einstein College of Medicine included Director and Manager of the Institutional Review Board (IRB), Assistant Manager, Data Manager, and Data Analyst. He has also held positions such as Practicum Student at The Care Management Company of Montefiore Medical Center and Engineer Technician at Arcturus. His extensive experience in research and healthcare regulations underpins his current role at NYU Langone Health.
Involvement in Pre-Approval Access Initiatives
David Wallach is an active member of the Working Group on Compassionate Use and Pre-Approval Access (CUPA) since 2019. The group addresses ethical and regulatory challenges associated with access to investigational products before FDA approval. Wallach contributes his expertise in social media's role and legislative efforts surrounding pre-approval access. His involvement includes exploring regulatory solutions to facilitate compassionate use cases.